NIH funded study finds infection-related hospitalizations linked to increased risk of heart failure: Bethesda, Maryland Thursday, February 13, 2025, 18:00 Hrs [IST] A study funded ...
GenSight Biologics announces efficacy and safety results for Lumevoq gene therapy at the conclusion of the REFLECT phase III clinical study: Paris Thursday, February 13, 2025, 17: ...
Utthunga and VindAir to advance smart solutions for pharma and healthcare industries: Our Bureau, Bengaluru Thursday, February 13, 2025, 16:45 Hrs [IST] Utthunga, a leading provid ...
National Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing antibody (bnAb) administered prior to virus exposure protects macaques from ...
Shelton, Connecticut Thursday, February 13, 2025, 16:00 Hrs [IST] ...
Nandita Vijayasimha, Bengaluru Thursday, February 13, 2025, 08:00 Hrs [IST] ...
MaxCyte inks strategic platform license agreement with TG Therapeutics to advance its autoimmune cell therapeutics programmes: Rockville, Maryland Thursday, February 13, 2025, 10: ...
Palo Alto, California Thursday, February 13, 2025, 12:00 Hrs [IST] ...
Investors need to recognize Karnataka as destination where investments grow & innovation thrives: Kiran Mazumdar-Shaw: Nandita Vijayasimha, Bengaluru Thursday, February 13, 2025, ...
ICMR invites proposals for joint development of human vaccine against H5N1: Shardul Nautiyal, Mumbai Thursday, February 13, 2025, 08:00 Hrs [IST] The Indian Council of Medical Res ...
Alloy Therapeutics enters multi-year collaboration with Pfizer to develop new antibody discovery platform: Boston, Massachusetts Thursday, February 13, 2025, 13:00 Hrs [IST] Alloy ...
AIDCOC urges govt to establish grievance redressal mechanism to address issues related to drug regulations: Peethaambaran Kunnathoor, Chennai Thursday, February 13, 2025, 08:00 Hr ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback